Valuation: Devyser Diagnostics AB

Market Cap 1.01B 107M 91.36M 85.49M 78.25M 147M 10.21B 149M 394M 5.13B 400M 392M 16.96B P/E 2026 *
100x
P/E 2027 * 31.5x
Enterprise Value 963M 102M 87.11M 81.51M 74.61M 140M 9.73B 142M 376M 4.89B 382M 374M 16.17B EV / Sales 2026 *
3.92x
EV / Sales 2027 * 3.26x
Free-Float
70.22%
Yield 2026 *
-
Yield 2027 * -
1 day-1.34%
1 week-1.99%
Current month-10.74%
1 month-5.14%
3 months-40.82%
6 months-35.52%
Current year-48.34%
1 week 58.7
Extreme 58.7
66.8
1 month 58.7
Extreme 58.7
69.9
Current year 57.8
Extreme 57.8
114.8
1 year 57.8
Extreme 57.8
159.6
3 years 57.4
Extreme 57.4
159.6
5 years 56.1
Extreme 56.1
159.6
10 years 56.1
Extreme 56.1
159.6
Manager TitleAgeSince
Chief Executive Officer 59 04/08/2025
Director of Finance/CFO 43 01/01/2021
Chief Tech/Sci/R&D Officer 48 01/02/2024
Director TitleAgeSince
Chairman 57 27/05/2021
Director/Board Member 49 01/01/2021
Director/Board Member 72 01/01/2021
Date Insider Type Main position Quantity % Market Cap.
11/08/26 Buy

Director

5,000 0.0300%
04/08/26 Buy

Director

250 0.0015%
31/07/26 Buy

Director

2,533 0.0152%
Change 5-day change 1-year change 3-year change Capi.($)
-1.34%-1.99%-59.97%-21.96% 107M
-0.74%+3.81%+2.65%+23.14% 51.61B
-1.07%+2.82%+465.96%+570.70% 44.89B
+1.47%+9.79%+35.92%+20.21% 42.77B
+1.44%+7.77%+19.38%+84.65% 42.58B
-0.93%-4.33%+16.18%+55.82% 31.82B
+1.32%+7.30%+33.89%+148.53% 17.33B
-0.60%+1.93% - - 16.63B
0.00%+4.06%+9.14%+30.12% 14.76B
+1.28%+5.41%+82.40%+46.13% 14.09B
Average +0.08%+3.42%+67.28%+106.37% 27.66B
Weighted average by Cap. +0.14%+4.71%+99.28%+141.28%

Financials

2026 *2027 *
Net sales 246M 25.97M 22.25M 20.82M 19.06M 35.76M 2.49B 36.23M 95.91M 1.25B 97.52M 95.4M 4.13B 298M 31.42M 26.92M 25.19M 23.06M 43.27M 3.01B 43.84M 116M 1.51B 118M 115M 5B
Net income 10.07M 1.06M 911K 852K 780K 1.46M 102M 1.48M 3.93M 51.09M 3.99M 3.9M 169M 31.97M 3.38M 2.89M 2.71M 2.48M 4.65M 323M 4.71M 12.47M 162M 12.68M 12.4M 537M
Net Debt -47.04M -4.97M -4.26M -3.98M -3.64M -6.84M -475M -6.93M -18.35M -239M -18.65M -18.25M -790M -39M -4.12M -3.53M -3.3M -3.02M -5.67M -394M -5.75M -15.21M -198M -15.46M -15.13M -655M
Logo Devyser Diagnostics AB
Devyser Diagnostics AB is a Sweden-based company engaged in development, manufacture ad sale of kits for genetic testing in routing diagnostic to laboratories. The products are used for complex deoxyribonucleic acid (DNA) testing in the areas of hereditary diseases, oncology, and post-transplantation monitoring in order to diagnose genetic diseases and target cancer treatment. The company has since its inception developed and launched almost 30 products for routine diagnostic use, including Devyser Thrombophilia assay as well as Devyser Resolution XY for analysis of chromosomes X and Y. Devyser Diagnostics’ products are sold directly to the end customer or through hired distributors. The Company provides its products in more than 45 countries.
Employees
110
Date Price Change Volume
24/08/26 SEK 59.00 -1.34% 10,322
21/08/26 SEK 59.80 -2.13% 22,560
20/08/26 SEK 61.10 +1.50% 6,980
19/08/26 SEK 60.20 -0.33% 6,433
18/08/26 SEK 60.40 +0.33% 4,632
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
40.43DKK
Average target price
65.94DKK
Spread / Average Target
+63.11%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DVYSR Stock